Interest Expense Nonoperating

Name: Amphastar Pharmaceuticals Interest Expense Nonoperating by Business Segments
Creator: OpenCapital
License: https://www.opencapital.sh/terms

Amphastar Pharmaceuticals·Business Segments·1 segment·Rolls up to Interest Expense

Breakdown

Segment	Q1 '25	Q1 '26
Pharmaceutical Products	$6.29M	$6.55M
Total	$6.29M	$6.55M

Segments

Pharmaceutical ProductsView metric